Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: A multi-center study

Gynecologic Oncology

Volumn 118, Issue 3, 2010, Pages 283-288

  Kim, Hee Seung ^a   Park, Chan Yong ^b   Lee, Jong Min ^c   Lee, Jae Kwan ^d   Cho, Chi Heum ^e   Kim, Seok Mo ^f   Kim, Jae Weon ^a  

^a Seoul National University   (South Korea)

^b Gachon University   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Dongsan Medical Center   (South Korea)

^f Chonnam National University   (South Korea)

Author keywords

Endometrioid endometrial cancer; Preoperative; Prognostic factors; Serum CA 125 levels; Survival

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PACLITAXEL;

ADJUVANT THERAPY; ADNEXA DISEASE; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; COUNSELING; DIAGNOSTIC ACCURACY; ENDOMETRIOID CARCINOMA; ENDOMETRIOID ENDOMETRIAL CANCER; FEMALE; HIGH RISK BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; OVARIAN PRESERVATION; OVERALL SURVIVAL; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CARCINOMA, ENDOMETRIOID; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; COUNSELING; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 77955550569     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.04.018     Document Type: Article

References (30)

1. K. Kim, and S.Y. Ryu Major clinical research advances in gynecologic cancer 2009 J Gynecol Oncol 20 2009 203 209
2. A. Kong, I. Simera, M. Collingwood, C. Williams, and H. Kitchener Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis Ann Oncol 18 2007 1595 1604
3. W.T. Creasman, F. Odicino, P. Maisonneuve, M.A. Quinn, U. Beller, and J.L. Benedet Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 Suppl 1 2006 S105 S143
4. A.K. Sood, R.E. Buller, R.A. Burger, J.D. Dawson, J.I. Sorosky, and M. Berman Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome Obstet Gynecol 90 1997 441 447
5. D.J. Dotters Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 182 2000 1328 1334
6. J.D. Bloss, M.L. Berman, L.P. Bloss, and R.E. Buller Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patient Gynecol Oncol 40 1991 74 77
7. H.S. Kim, N.H. Park, H.H. Chung, J.W. Kim, Y.S. Song, and S.B. Kang Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer Onkologie 31 2008 315 320
8. P.G. Rose, R.M. Sommers, F.R. Reale, R.E. Hunter, L. Fournier, and B.E. Nelson Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma Obstet Gynecol 84 1994 12 16
9. J.M. Duk, J.G. Aalders, G.J. Fleuren, and H.W. de Bruijn CA 125: a useful marker in endometrial carcinoma Am J Obstet Gynecol 155 1986 1097 1102
10. J.M. Duk, J.G. Aalders, G.J. Fleuren, M. Krans, and H.W. De Bruijn Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix Obstet Gynecol 73 1989 661 668
11. J.T. Soper, A. Berchuck, G.J. Olt, A.P. Soisson, D.L. Clarke-Pearson, and R.C. Bast Jr Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma Am J Obstet Gynecol 163 1990 1204 1209
12. S.S. Lo, D.K. Cheng, T.Y. Ng, L.C. Wong, and H.Y. Ngan Prognostic significance of tumour markers in endometrial cancer Tumour Biol 18 1997 241 249
13. M. Santala, A. Talvensaari-Mattila, and A. Kauppila Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer Anticancer Res 23 2003 3097 3103
14. D. Denschlag, L. Tan, S. Patel, A. Kerim-Dikeni, L. Souhami, and L. Gilbert Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome Am J Obstet Gynecol 196 546 2007 e1 e7
15. A.P. Heintz, F. Odicino, P. Maisonneuve, W.T. Creasman, U. Beller, and M.A. Quinn Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 Suppl 1 2006 S161 S192
16. R.C. Bast Jr., T.L. Klug, E. St John, E. Jenison, J.M. Niloff, and H. Lazarus A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer N Engl J Med 309 1983 883 887
17. A. Gadducci, S. Cosio, A. Carpi, A. Nicolini, and A.R. Genazzani Serum tumor markers in the management of ovarian, endometrial and cervical cancer Biomed Pharmacother 58 2004 24 38
18. C.H. Hsieh, C.C. ChangChien, H. Lin, E.Y. Huang, C.C. Huang, and K.C. Lan Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86 2002 28 33
19. G. Scambia, A. Gadducci, P.B. Panici, E. Foti, M. Ferdeghini, and G. Ferrandina Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma Gynecol Oncol 54 1994 292 297
20. S. Ginath, J. Menczer, Y. Fintsi, E. Ben-Shem, M. Glezerman, and I. Avinoach Tissue and serum CA125 expression in endometrial cancer Int J Gynecol Cancer 12 2002 372 375
21. P. Lehtovirta, B. Cacciatore, and P. Ylostalo Serum CA 125 levels and sonography in the pre-operative assessment of myometrial invasion of endometrial cancer Br J Obstet Gynaecol 101 1994 532 535
22. J.L. Powell, K.A. Hill, B.C. Shiro, S.J. Diehl, and W.H. Gajewski Preoperative serum CA-125 levels in treating endometrial cancer J Reprod Med 50 2005 585 590
23. N.P. Koper, L.F. Massuger, C.M. Thomas, L.A. Kiemeney, and A.L. Verbeek Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy Anticancer Res 18 1998 1897 1902
24. H.H. Chung, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer Acta Obstet Gynecol Scand 85 2006 1501 1505
25. I. Takac, and B. Gorisek Serum CA 125 levels and lymph node metastasis in patients with endometrial cancer Wien Klin Wochenschr 118 Suppl 2 2006 62 65
26. L.T. Shuster, B.S. Gostout, B.R. Grossardt, and W.A. Rocca Prophylactic oophorectomy in premenopausal women and long-term health Menopause Int 14 2008 111 116
27. C. Walsh, C. Holschneider, Y. Hoang, K. Tieu, B. Karlan, and I. Cass Coexisting ovarian malignancy in young women with endometrial cancer Obstet Gynecol 106 2005 693 699
28. J.M. Riedinger, J. Wafflart, G. Ricolleau, N. Eche, H. Larbre, and J.P. Basuyau CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study Ann Oncol 17 2006 1234 1238
29. A. Santillan, R. Garg, M.L. Zahurak, G.J. Gardner, R.L. Giuntoli II, and D.K. Armstrong Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range J Clin Oncol 23 2005 9338 9343
30. P.M. Fayers, G. Rustin, R. Wood, A. Nelstrop, R.C. Leonard, and P. Wilkinson The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer Int J Gynecol Cancer 3 1993 285 292